IRMD

iRadimed Corporation
Data: 2026-08-21
$87.85
Price
1.35%
Change
$107.90
52W High
$67.84
52W Low

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Quick Stats
Aug 21, 2026

53.8

AI Score

HOLD

0.6

Volume Ratio

TBA

Next Earnings

11

+ve Days (30d)

18

-ve Days (30d)

IRMD Stock Summary

Last updated Aug 21, 2026

IRMD is currently trading at $87.85, positioned below its 200-day moving average of $94.4, suggesting bearish momentum. The stock has a 52-week range of $67.8421 to $107.9.

Technical Analysis: The 50-day moving average stands at $93.32, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.389, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.302, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates IRMD at 53.8/100 with a HOLD recommendation.

IRMD (iRadimed Corporation) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 40.389
CMF (20) -0.302
ROC (10) -5.022
ADX (14) 29.492
Indicator Value
MACD (12,26,9) -1.947
AROONOSC (14) -64.286
WILLAMS %R (14) -70.709
MFI (14) 38.783
IRMD Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

IRMD Price vs Max Options Open Interest
IRMD Max Change In Options Open Interest

IRMD Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

IRMD Daily Out of Money Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

IRMD Daily In the Money Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

IRMD Most Active Options by Volume(near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

iRadimed Corporation is below both the 50 Day and 200 Day SMA which is considered Bearish.

IRMD Moving Averages Analysis

IRMD (iRadimed Corporation) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 87.82
20 90.44
30 92.03
50 93.32
100 91.97
200 94.4

IRMD Fundamental Analysis

P/E (Forward) 41.1523
P/E (Trailing) 48.9718
Market Cap ($) 1.1 billion
Earnings/Share ($) 1.77
Net Profit Margin (%) 0.267
Dividend/Share ($) 0.77
EPS Estimate Current Year ($) 2.09
EPS Estimate Next Year ($) 2.41
WallStreet Target Price ($) 118.00
Most Recent Quarter